Zinilisib
Zinilisib (Zinilisibum) is a PI3K inhibitor. Zinilisib potently inhibits the phosphorylation of AKT in cells expressing mutant PI3KαH1047R and wild-type PI3Kα, with IC50 values of 1-500 nM and 2-15 μM, respectively. Zinilisib can be used in breast cancer-related research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 3031974-57-6
- 화학식: C26H29F3N4O3
- 분자량:502.53
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Zinilisib (Example 8) potently inhibits the proliferation of T47D cells expressing mutant PI3KαH1047R, with a mean EC50 ranging from 1 nM to 500 nM; it also inhibits the proliferation of SKBR3 cells expressing wild-type PI3Kα, with a mean EC50 ranging from 2 μM to 15 μM[2].
Zinilisib (6 h) potently inhibits AKT phosphorylation in T47D cells expressing mutant PI3KαH1047R, with a mean IC50 ranging from 1 nM to 500 nM; it also inhibits AKT phosphorylation in SKBR3 cells expressing wild-type PI3Kα, with a mean IC50 ranging from 2 μM to 15 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:T47D cells expressing mutant PI3Kα (H1047R), SKBR3 cells expressing wild-type PI3Kα
-
Concentration:10-point dilution series
-
Incubation Time:72 h
-
Result:Inhibited proliferation of T47D cells with an average EC50 in the range of 1 nM to 500 nM.
Inhibited proliferation of SKBR3 cells with an average EC50 in the range of 2 μM to 15 μM.
Chemical Information
-
CAS No. 3031974-57-6
-
분자량 502.53
-
화학식 C26H29F3N4O3
-
SMILES
OC(C(C=CC=C1)=C1N[C@@H](C2=C3C(C(N(C(N4CCN(CC4)CC(F)(F)F)=C3)C)=O)=CC(C)=C2)C)=O
-
Synonyms
zinilisibum
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)